Aperion Biologics

Aperion Biologics was a private U.S. orthobiologics and medical device company focused on animal-derived tissue grafts intended as alternatives to human allografts for surgical repair and reconstruction. The company developed processing technology designed to make xenogeneic tissue, particularly porcine tendon-based materials, suitable for human use with reduced rejection risk. Its lead product family included the Z-Lig graft platform for orthopedic and soft tissue applications. Available sources indicate the company is no longer active and is generally described as closed or out of business. Aperion appears to have operated primarily in regenerative medicine and therapeutic devices rather than traditional drug development.